University of Illinois-Chicago: New Therapy From UI Health Offers FDA-Approved Treatment Option for Brittle Type 1 Diabetes
November 27, 2024
November 27, 2024
CHICAGO, Illinois, Nov. 27 (TNSres) -- The University of Illinois Chicago campus issued the following news release:
A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is available exclusively at UI Health in Chicago.
Pancreatic islet cell therapy is a treatment approved by the FDA only for adults with type 1 diabetes who struggle to control their blood sugar levels due to frequent episodes of severe . . .
A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is available exclusively at UI Health in Chicago.
Pancreatic islet cell therapy is a treatment approved by the FDA only for adults with type 1 diabetes who struggle to control their blood sugar levels due to frequent episodes of severe . . .